These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31422691)

  • 1. Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.
    Bae EH; Lim SY; Han KD; Oh TR; Choi HS; Kim CS; Ma SK; Kim SW
    Hypertension; 2019 Oct; 74(4):880-887. PubMed ID: 31422691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.
    Kim MK; Han K; Koh ES; Kim HS; Kwon HS; Park YM; Yoon KH; Lee SH
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1963-1970. PubMed ID: 28860222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
    Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
    Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study.
    Lee YB; Lee JS; Hong SH; Kim JA; Roh E; Yoo HJ; Baik SH; Choi KM
    Sci Rep; 2021 Jan; 11(1):1538. PubMed ID: 33452422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
    Bell EK; Gao L; Judd S; Glasser SP; McClellan W; Gutiérrez OM; Safford M; Lackland DT; Warnock DG; Muntner P
    Am J Hypertens; 2012 Jul; 25(7):789-96. PubMed ID: 22573012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
    Rossignol P; Cridlig J; Lehert P; Kessler M; Zannad F
    Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy).
    Arashi H; Ogawa H; Yamaguchi J; Kawada-Watanabe E; Hagiwara N
    Am J Cardiol; 2015 Jul; 116(2):236-42. PubMed ID: 25966826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
    Chang TI; Tabada GH; Yang J; Tan TC; Go AS
    J Hypertens; 2016 Feb; 34(2):244-52. PubMed ID: 26599220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).
    Peralta CA; Norris KC; Li S; Chang TI; Tamura MK; Jolly SE; Bakris G; McCullough PA; Shlipak M;
    Arch Intern Med; 2012 Jan; 172(1):41-7. PubMed ID: 22232147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
    Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
    Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study.
    Geng TT; Talaei M; Jafar TH; Yuan JM; Koh WP
    J Am Heart Assoc; 2019 Dec; 8(23):e013282. PubMed ID: 31766974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults.
    Chang TI; Lim H; Park CH; Rhee CM; Moradi H; Kalantar-Zadeh K; Kang EW; Kang SW; Han SH
    Am J Kidney Dis; 2020 Aug; 76(2):224-232. PubMed ID: 32305207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C-STRIDE.
    Wang Q; Wang Y; Wang J; Zhang L; Zhao MH;
    J Am Heart Assoc; 2020 Jun; 9(12):e015359. PubMed ID: 32508195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Arteriovenous Fistula Creation on Systolic and Diastolic Blood Pressure in Patients With Pre-dialysis Advanced Chronic Kidney Disease.
    Mathew RO; Fleg J; Rangaswami J; Cai B; Asif A; Sidhu MS; Bangalore S
    Am J Hypertens; 2019 Aug; 32(9):858-867. PubMed ID: 31150056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure-Related Risk Among Users Versus Nonusers of Antihypertensives: A Population-Based Cohort in Korea.
    Jung HH; Park JI; Jeong JS
    Hypertension; 2018 Jun; 71(6):1047-1055. PubMed ID: 29686015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease.
    Agarwal R; Andersen MJ
    Kidney Int; 2006 Apr; 69(7):1175-80. PubMed ID: 16467785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.